- Governments are striving to get aid in the form of drugs for treating infected individuals, as well as to avoid further spread of the virus.
- Development of nucleic acid vaccines that are DNA- and RNA-based, enable the human body to produce vaccine antigen.
- Novel Coronavirus is thought to possibly have zoological origin
The 2019-nCoV or 2019 novel coronavirus, also known as the Wuhan coronavirus, is highly contagious in nature and causes severe respiratory infections. This virus was first identified by healthcare authorities in Wuhan, China in 2019, due to the ongoing 2019–2020 coronavirus outbreak in the city.
Certain reports stated that Wuhan coronavirus had epidemiological link to seafood and animals, due to which, this virus is thought to possibly have zoological origin, though it has not been confirmed yet. 2019-nCoV, when compared to genetic sequences of other existing viruses, has shown some similarities to SARS-CoV of around 79.5% as well as 96% similarities to bat coronaviruses.
Drivers and Restraints
Technological advancements in the pharmaceutical sector include development of nucleic acid vaccines that are DNA- and RNA-based, enabling the human body to produce vaccine antigen. Such initiatives and activities is projected to support market growth to a significant extent.
(Our FREE SAMPLE COPY of the report gives a brief introduction to the research report outlook, TOC, list of tables and figures, an outlook to key players of the market and comprising key regions.)
Other primary factors include increasing spending on the healthcare sector, growing concerns regarding outbreaks at regular intervals, and rising need to protect the population from known and unknown viruses. The 2019–2020 coronavirus outbreak could have negative impact on growth of various markets, thereby affecting global GDP. For instance, tourism in the semi-autonomous Chinese territory of Macao has dropped by 73.6% from 2019 to 2020 amid the Wuhan coronavirus outbreak, according to statistics released by the government recently.
Governments and healthcare authorities are striving to get aid in the form of drugs for treating infected individuals, as well as to avoid further spread of the virus.
Key Players: Inovio Pharmaceuticals Inc, Moderna Inc, Novavax Inc, Protein Potential LLC, AlphaVax Inc, Synairgen PLC, NanoViricides Inc, GGeneCure LLC.
- Buy Research Report: Cough Suppressant Drugs Market to Witness a CAGR of 3.7% During the Forecast Period (2018 – 2026)
- Buy Research Report: Lab Automation Market to Reflect Impressive Growth in Pharmaceuticals and Biotechnology Industry
- Buy Research Report: Plasma Fractionation Market to Expand 1.5x through 2026, Convalescent Plasma (CP) Treatment amid COVID-19 to Inject Hope
- Buy Research Report: Medical Holography Market to Surge, Finds Significant Potential in Diagnosis of COVID-19
- Buy Research Report: Epinephrine Market to Exhibit at a CAGR of 11.0% Over the Forecast Period (2018 – 2026)
Segmentation By Infection Type (Caused by Coronavirus): HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV.
Segmentation By Vaccine Type: Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, S-Protein based coronavirus vaccine.
Segmentation By End User: Hospitals, Clinics, Research Institutes
This report is a systematic and insightful compilation of valuable assessments of Coronavirus
Vaccine Market and applicable perspectives. The report offers an in depth exploration of the market and its extension, patterns, structure, creation, profitability and development. The exact assessment of market size, share, income, deals volume, request, and pace of development required inside the report drive speculators, industry experts, researchers, also as fledgling and settled market players to get a handle on the general Coronavirus Vaccine Market structure.
What does the Coronavirus Vaccine market report contain?
Segmentation of the Coronavirus Vaccine market to focus on the expansion outlook and trends affecting these segments. Examination of the serious scene into showcase and provincial entrance, acquisitions, and concurrences with SWOT investigation. Consumption behavior of every segment of the Coronavirus Vaccine market in every region. Thorough analysis of the impacts of the expansion of relevant industries. In-depth insights about the recent R&D projects performed by each Coronavirus Vaccine market player.
Readers can get the answers of the subsequent questions while browsing the Coronavirus Vaccine market report: Which segment will have the utmost share of the worldwide Coronavirus Vaccine market by the top of 2029? What opportunities are available for the Coronavirus Vaccine market players to expand their production footprint? What are the pros and cons of the Coronavirus Vaccine on human health? Which players are getting into partnerships and why? Why the demand for the Coronavirus Vaccine highest in region?